| Air | Acid | ||
---|---|---|---|---|
Mediator (pg/ml) | No treatment | bLES | No treatment | bLES |
Eotaxin | 17.4 ± 1.3 | 25.7 ± 0.9 | 135.2 ± 13.6* | 142.8 ± 15.9* |
G-CSF | 45.9 ± 10.5 | 59.4 ± 3.4 | 890.8 ± 75.8 | 1270.3 ± 187.8* |
GM-CSF | 0 | 0 | 13.4 ± 2.8 | 16.3 ± 2.2 |
IL-6 | 567.7 ± 62.7 | 1119.0 ± 99.1 | 8303.2 ± 323.6* | 10720.1 ± 764.2* |
IL-1 β | 1.0 ± 0.40 | 0.2 ± 0.1 | 0.3 ± 0.1 | 3.2 ± 0.6 |
KC | 579.2 ± 65.8 | 907.0 ± 75.4 | 3617.2 ± 174.3* | 6212.7 ± 504.8* |
LIX | 113.7 ± 11.1 | 98.3 ± 13.0 | 284.6 ± 17.9 | 447.4 ± 31.9* |
MCP-1 | 12.9 ± 1.8 | 30.9 ± 4.9 | 337.4 ± 26.2 | 558.0 ± 71.5* |
MIP-2 | 584.4 ± 68.2 | 725.7 ± 41.9 | 1840.2 ± 76.7* | 3113.4 ± 204.8*,# |
TNF-α | 63.4 ± 11.6 | 72.2 ± 7.0 | 119.7 ± 3.1 | 143.3 ± 8.1 |
IP-10 | 32.9 ± 3.6 | 40.8 ± 1.7 | 391.3 ± 80.8 | 283.3 ± 27.7 |